Kenneth S. Cohen to Follow-Up Studies
This is a "connection" page, showing publications Kenneth S. Cohen has written about Follow-Up Studies.
Connection Strength
0.307
-
A phase I trial of arsenic trioxide chemoradiotherapy for infiltrating astrocytomas of childhood. Neuro Oncol. 2013 Jun; 15(6):783-7.
Score: 0.065
-
Temozolomide in the treatment of high-grade gliomas in children: a report from the Children's Oncology Group. Neuro Oncol. 2011 Mar; 13(3):317-23.
Score: 0.057
-
Visante OCT measurement of central corneal thickness following Descemet's stripping endothelial keratoplasty. Ophthalmic Surg Lasers Imaging. 2010 Dec 01; 41 Online:e1-3.
Score: 0.056
-
Tectal gliomas: natural history of an indolent lesion in pediatric patients. Pediatr Neurosurg. 2000 Jan; 32(1):24-9.
Score: 0.026
-
Prospective feasibility and safety assessment of surgical biopsy for patients with newly diagnosed diffuse intrinsic pontine glioma. Neuro Oncol. 2018 10 09; 20(11):1547-1555.
Score: 0.024
-
Phase I study of oral sonidegib (LDE225) in pediatric brain and solid tumors and a phase II study in children and adults with relapsed medulloblastoma. Neuro Oncol. 2017 Oct 19; 19(11):1542-1552.
Score: 0.023
-
A pediatric trial of radiation/cetuximab followed by irinotecan/cetuximab in newly diagnosed diffuse pontine gliomas and high-grade astrocytomas: A Pediatric Oncology Experimental Therapeutics Investigators' Consortium study. Pediatr Blood Cancer. 2017 Nov; 64(11).
Score: 0.022
-
Phase 2 study of safety and efficacy of nimotuzumab in pediatric patients with progressive diffuse intrinsic pontine glioma. Neuro Oncol. 2014 Nov; 16(11):1554-9.
Score: 0.018
-
Association between radiation dose to neuronal progenitor cell niches and temporal lobes and performance on neuropsychological testing in children: a prospective study. Neuro Oncol. 2013 Mar; 15(3):360-9.
Score: 0.016